Related Experiment Video

Updated: Apr 23, 2026

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.3K

Is target validation all we need?

Melanie M Frigault1, J Carl Barrett1

  • 1Oncology Translational Science, AstraZeneca, Waltham, MA, USA.

Current Opinion in Pharmacology
|September 28, 2014
PubMed

Insights

Target validation alone is insufficient for effective cancer therapies. Understanding tumor biology, drug chemistry, and resistance mechanisms is crucial for successful precision medicine development.

Area of Science:

  • Oncology
  • Pharmacology
  • Cancer Biology

Background:

  • The development of targeted cancer therapies represents a paradigm shift from traditional chemotherapy.
  • Precision medicines require a deep understanding of cancer biology beyond simple target identification.

Purpose of the Study:

  • To evaluate whether target validation is sufficient for the development of efficacious targeted cancer therapies.
  • To identify key elements of tumor biology and drug chemistry that influence clinical validation of novel targets.

Main Methods:

  • Review of current approaches in targeted cancer therapy development.
  • Analysis of factors influencing the clinical efficacy of targeted agents, including target reproducibility, modulation, resistance, and heterogeneity.

Main Results:

  • Target validation is a necessary but not sufficient step in developing targeted cancer therapies.
  • Reproducibility of targets, extent and duration of target modulation, feedback loops, acquired resistance mechanisms, and tumor heterogeneity significantly impact clinical success.
  • Understanding these biological and chemical factors is essential for optimizing drug development and combination strategies.

Conclusions:

  • Successful clinical validation of targeted cancer therapies requires a comprehensive understanding of tumor biology and drug chemistry.
  • Addressing target reproducibility, modulation dynamics, resistance, and heterogeneity can enhance the development of more effective precision medicines.
  • Further research into these elements will improve targeted treatment options for cancer patients.

More Related Videos

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.2K
A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

14.5K

Related Concept Videos

Data Validation01:03

Data Validation

Data validation is an essential part of a comprehensive assessment. Validation is confirming or verifying and opening the door to gathering more assessment data as it clarifies vague or unclear data. The process of checking and verifying the collected information is called data validation. The primary purpose of data validation is to ensure data is as free from error, bias, and misinterpretation as possible.
Nursing assessment guides are generally based on holistic models rather than medical...
6.4K
Reliability and Validity01:29

Reliability and Validity

Reliability and validity are two important considerations that must be made with any type of data collection. Reliability refers to the ability to consistently produce a given result. In the context of psychological research, this would mean that any instruments or tools used to collect data do so in consistent, reproducible ways.
12.8K
Accuracy and Errors in Hypothesis Testing01:13

Accuracy and Errors in Hypothesis Testing

Hypothesis testing is a fundamental statistical tool that begins with the assumption that the null hypothesis H0 is true. During this process, two types of errors can occur: Type I and Type II. A Type I error refers to the incorrect rejection of a true null hypothesis, while a Type II error involves the failure to reject a false null hypothesis.
In hypothesis testing, the probability of making a Type I error, denoted as α, is commonly set at 0.05. This significance level indicates a 5%...
712
Sensitivity, Specificity, and Predicted Value01:13

Sensitivity, Specificity, and Predicted Value

In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
1.9K
Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
339
Multiple Comparison Tests01:13

Multiple Comparison Tests

Multiple comparison test, abbreviated as MCT, is a post hoc analysis generally performed after comparing multiple samples with one or more tests. An MCT will help identify a significantly different sample among multiple samples or a factor among multiple factors.
It would be easy to compare two samples using a significance alpha level of 0.05. In other words, there is only one sample pair to be compared. However, it would be difficult to identify a significantly different sample if the number...
3.4K